Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
Tags:
InterMune, Esbriet, Alexion, Soliris, Vivus, Qsymia, Regeneron, Eylea
Regeneron Chief Leonard Schleifer Becomes A Billionaire After 25 Year Search For New Drugs
Forbes
Wed, 02/26/14 - 11:04 am
Tags:
Regeneron, Leonard Schleifer, executive pay
One Reason the Biotech Boom Won’t Turn to Bust
Barron's
Tue, 02/25/14 - 11:17 am
Tags:
biotech, Biogen Idec, Regeneron
No Looking Back for Regeneron's Eylea
Yahoo/Zacks.com
Tue, 02/25/14 - 11:05 am
Tags:
Regeneron, Eylea, BRVO
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
Tags:
biotech, Celgene, Gilead Sciences, Biogen Idec, Amgen, Regeneron
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wed, 02/19/14 - 09:26 am
Tags:
Regeneron, Eylea, Gilead Sciences, ledipasvir, Sovaldi, hepatitis C, Cangrelor, The Medicines Company
Breakout Week for Biotech? Comment Now Follow Comments
Forbes
Tue, 02/11/14 - 10:37 am
Tags:
Seattle Genetics, Regeneron
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Tue, 02/11/14 - 08:52 am
Tags:
Regeneron, Arcalyst, Eylea, Zaltrap
Is There Investment Upside In The Future Of Treating Diabetes?
Seeking Alpha
Mon, 02/10/14 - 08:43 am
Tags:
diabetes, MannKind, Merck, Novo Nordisk, NeoStem, Regeneron
Can Biotech Dominate for a 4th Year in a Row?
Motley Fool
Mon, 02/3/14 - 09:35 am
Tags:
biotech, IPOs, Amgen, Ariad Pharmaceuticals, Regeneron
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal
Yahoo/Zacks.com
Wed, 01/22/14 - 04:14 pm
Tags:
Sarepta Therapeutics, Alnylam, Jazz Pharmaceuticals, Regeneron, Celgene
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
Tags:
earnings, United Therapeutics, Celgene, Regeneron, Biogen Idec, Acorda Therapeutics, Amgen, Gilead Sciences
Illumina, Regeneron, Intuitive Q4 Results Impress
Investors.com
Wed, 01/15/14 - 08:58 am
Tags:
earnings, Illumina, Regeneron, Intuitive Surgical
Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Mon, 01/6/14 - 04:34 pm
Tags:
Cubist, Regeneron, Spectrum
Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus
Barron's
Mon, 01/6/14 - 11:44 am
Tags:
biotech, Amgen, Regeneron
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
Tags:
biotech, Vertex Pharmaceuticals, Orexigen, Retrophin, Valeant Pharmaceuticals, Questcor, Biomarin, Merck, NeoStem, Amgen, Gilead Sciences, Vanda, Keryx, Peregrine Pharmaceuticals, CelSci, Regeneron, Cempra, Dendreon, Clovis Oncology, Halozyme, NPS Pharmaceuticals
3 Health Care Stocks Dragging The Sector Down
TheStreet.com
Fri, 01/3/14 - 12:54 pm
Tags:
Illumina, Alexion, Regeneron
Jim Cramer: Ride the Four Horsemen of Biotech
TheStreet.com
Fri, 12/27/13 - 09:34 am
Tags:
biotech, Biogen Idec, Celgene, Gilead Sciences, Regeneron
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Tags:
Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
Tags:
pSivida, ophthalmology, GSK, Novartis, Pfizer, Regeneron, Roche, Sanofi, Iluvien, Durasert, Medidur

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.